References
Key articles
Mehregan DA, Van Hale HM, Muller SA. Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol. 1992 Dec;27(6 Pt 1):935-42. Abstract
Scott MJ Jr, Scott MJ Sr. Ungual lichen planus: lichen planus of the nail. Arch Dermatol. 1979 Oct;115(10):1197-9. Abstract
Balasubramaniam P, Ogboli M, Moss C. Lichen planus in children: review of 26 cases. Clin Exp Dermatol. 2008 Jul;33(4):457-9. Abstract
Lodi G, Giuliani M, Majorana A, et al. Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol. 2004 Dec;151(6):1172-81. Abstract
Usatine RP, Tinitigan M. Diagnosis and treatment of lichen planus. Am Fam Physician. 2011 Jul 1;84(1):53-60. Abstract
Chieregato C, Zini A, Barba A, et al. Lichen planopilaris: report of 30 cases and review of the literature. Int J Dermatol. 2003 May;42(5):342-5. Abstract
Scully C, Carrozzo M. Oral mucosal disease: Lichen planus. Br J Oral Maxillofac Surg. 2008 Jan;46(1):15-21. Abstract
Byrd JA, Davis MD, Bruce AJ, et al. Response of oral lichen planus to topical tacrolimus in 37 patients. Arch Dermatol. 2004 Dec;140(12):1508-12.Full text Abstract
Cheng S, Kirtschig G, Cooper S, et al. Interventions for erosive lichen planus affecting mucosal sites. Cochrane Database Syst Rev. 2012;(2):CD008092.Full text Abstract
Lodi G, Carrozzo M, Furness S, et al. Interventions for treating oral lichen planus: a systematic review. Br J Dermatol. 2012 May;166(5):938-47. Abstract
Edwards SK, Bates CM, Lewis F, et al. 2014 UK national guideline on the management of vulval conditions. Int J STD AIDS. 2015 Aug;26(9):611-24. Abstract
Reference articles
1. Pittelkow MR, Daoud MS. Lichen planus. In: Wolff K, Goldsmith LA, Katz SI, et al, eds. Fitzpatrick's dermatology in general medicine. Vol One. 7th ed. New York, NY: McGraw-Hill Companies, Inc.; 2008:244-255.
2. Boyd AS, Neldner KN. Lichen planus. J Am Acad Dermatol. 1991 Oct;25(4):593-619. Abstract
3. Dissemond J. Oral lichen planus: an overview. J Dermatolog Treat. 2004 Jun;15(3):136-40. Abstract
4. Goldstein AT, Metz A. Vulvar lichen planus. Clin Obstet Gynecol. 2005 Dec;48(4):818-23. Abstract
5. Mehregan DA, Van Hale HM, Muller SA. Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol. 1992 Dec;27(6 Pt 1):935-42. Abstract
6. Cevasco NC, Bergfeld WF, Remzi BK, et al. A case-series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. J Am Acad Dermatol. 2007 Jul;57(1):47-53. Abstract
7. Scott MJ Jr, Scott MJ Sr. Ungual lichen planus: lichen planus of the nail. Arch Dermatol. 1979 Oct;115(10):1197-9. Abstract
8. Harewood GC, Murray JA, Cameron AJ. Esophageal lichen planus: the Mayo Clinic experience. Dis Esophagus. 1999;12(4):309-11. Abstract
9. Ber Rahman S, Ul Bari A, Mumtaz N. Unilateral Blaschkoid lichen planus involving the entire half of the body, a unique presentation. Dermatol Online J. 2007 Jul 13;13(3):36.Full text Abstract
10. Rajeev S, Veena M, Mithilesh C. Unilateral multiple linear lichen planus along the lines of Blaschko: a report of two cases. Indian J Dermatol Venereol Leprol. 1999;65:225-226.
11. Kabbash C, Laude TA, Weinberg JM, et al. Lichen planus in the lines of Blaschko. Pediatr Dermatol. 2002 Nov-Dec;19(6):541-5. Abstract
12. Mohrenschlager M, Engst R, Hein R, et al. Primary manifestations of a zosteriform lichen planus: isotopic response following herpes zoster sine herpete? Br J Dermatol. 2008 May;158(5):1145-6. Abstract
13. Kashima A, Tajiri A, Yamashita A, et al. Two Japanese cases of lichen planus pigmentosus-inversus. Int J Dermatol. 2007 Jul;46(7):740-2. Abstract
14. Peretz E, Grunwald MH, Halevy S. Annular plaque on the face. Actinic lichen planus (ALP). Arch Dermatol. 1999 Dec;135(12):1543, 1546. Abstract
15. Morales-Callaghan A Jr, Martinez G, Aragoneses H, et al. Annular atrophic lichen planus. J Am Acad Dermatol. 2005 May;52(5):906-8. Abstract
16. Akay BN, Arslan A, Cekirge S, et al. The first reported case of lichen planus following inactivated influenza vaccination. J Drugs Dermatol. 2007 May;6(5):536-8. Abstract
17. Agrawal A, Shenoi SD. Lichen planus secondary to hepatitis B vaccination. Indian J Dermatol Venereol Leprol. 2004 Jul-Aug;70(4):234-5.Full text Abstract
18. Copeman PW, Schroeter AL, Kierland RR. An unusual variant of lupus erythematosus or lichen planus. Br J Dermatol. 1970 Aug;83(2):269-72. Abstract
19. Nagao K, Chen KR. A case of lupus erythematosus/lichen planus overlap syndrome. J Dermatol. 2006 Mar;33(3):187-90. Abstract
20. Pandhi D, Singal A, Bhattacharya SN. Lichen planus in childhood: a series of 316 patients. Pediatr Dermatol. 2014 Jan-Feb;31(1):59-67. Abstract
21. Balasubramaniam P, Ogboli M, Moss C. Lichen planus in children: review of 26 cases. Clin Exp Dermatol. 2008 Jul;33(4):457-9. Abstract
23. Bhattacharya A, Kaur I, Kumar B. Lichen planus: a clinical and epidemiological study. J Dermatol. 2000 Sep;27(9):576-82. Abstract
24. Lodi G, Giuliani M, Majorana A, et al. Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol. 2004 Dec;151(6):1172-81. Abstract
25. Kazandjieva J, Tsankov N. Tattoos: dermatological complications. Clin Dermatol. 2007 Jul-Aug;25(4):375-82. Abstract
26. Yiannias JA, el-Azhary RA, Hand JH, et al. Relevant contact sensitivities in patients with the diagnosis of oral lichen planus. J Am Acad Dermatol. 2000 Feb;42(2 Pt 1):177-82. Abstract
27. Sklavounou-Andrikopoulou A, Chrysomali E, Iakovou M, et al. Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas/Apo-1 and Bcl-2 in oral lichen planus. J Oral Pathol Med. 2004 Aug;33(7):386-90. Abstract
28. Rhodus NL, Cheng B, Ondrey F. Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus. Mediators Inflamm. 2007;2007:19854.Full text Abstract
29. Wenzel J , Tuting T. An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis". J Invest Dermatol. 2008 Oct;128(10):2392-402. Abstract
30. Norris DA. Cytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets. J Invest Dermatol. 1990 Dec;95(6 Suppl):111S-120S. Abstract
31. Chen X, Liu Z, Yue Q. The expression of TNF-alpha and ICAM-1 in lesions of lichen planus and its implication. J Huazhong Univ Sci Technolog Med Sci. 2007 Dec;27(6):739-41. Abstract
32. Bennion SD, Middleton MH, David-Bajar KM, et al. In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease. J Invest Dermatol. 1995 Jul;105(1 Suppl):71S-79S. Abstract
33. Hussein MR. Evaluation of angiogenesis in normal and lichen planus skin by CD34 protein immunohistochemistry: preliminary findings. Cell Biol Int. 2007 Oct;31(10):1292-5. Abstract
34. Daoud MS, Gibson LE, Daoud S, et al. Chronic hepatitis C and skin diseases: a review. Mayo Clin Proc. 1995 Jun;70(6):559-64. Abstract
35. Chainani-Wu N, Lozada-Nur F, Terrault N. Hepatitis C virus and lichen planus: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Aug;98(2):171-83. Abstract
36. Jin X, Wang J, Zhu L, et al. Association between -308 G/A polymorphism in TNF-α gene and lichen planus: a meta-analysis. J Dermatol Sci. 2012 Dec;68(3):127-34. Abstract
37. Manolache L, Seceleanu-Petrescu D, Benea V. Lichen planus patients and stressful events. J Eur Acad Dermatol Venereol. 2008 Apr;22(4):437-41. Abstract
38. Usatine RP, Tinitigan M. Diagnosis and treatment of lichen planus. Am Fam Physician. 2011 Jul 1;84(1):53-60. Abstract
39. Asarch A, Gottlieb AB, Lee J, et al. Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists. J Am Acad Dermatol. 2009 Jul;61(1):104-11. Abstract
40. Halevy S, Shai A. Lichenoid drug eruptions. J Am Acad Dermatol. 1993 Aug;29(2 Pt 1):249-55. Abstract
41. Vazquez-Lopez F, Gomez-Diez S, Sanchez J, et al. Dermoscopy of active lichen planus. Arch Dermatol. 2007 Aug;143(8):1092. Abstract
42. Kulthanan K, Jiamton S, Varothai S, et al. Direct immunofluorescence study in patients with lichen planus. Int J Dermatol. 2007 Dec;46(12):1237-41. Abstract
43. Fellner MJ. Lichen planus. Int J Dermatol. 1980 Mar;19(2):71-5. Abstract
44. Weedon D. Skin pathology. 2nd ed. St. Louis, MO: Elsevier Limited; 2002.
45. Thongprasom K, Carrozzo M, Furness S, et al. Interventions for treating oral lichen planus. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD001168. Abstract
46. Kellet JK, Ead RD. Treatment of lichen planus with short course of oral prednisolone. Br J Dermatol. 1990 Oct;123(4):550-1. Abstract
47. Laurberg G, Geiger JM, Hjorth N, et al. Treatment of lichen planus with acitretin: a double-blind, placebo-controlled study in 65 patients. J Am Acad Dermatol. 1991 Mar;24(3):434-7. Abstract
48. Pavlotsky F, Nathansohn N, Kriger G, et al. Ultraviolet-B treatment for cutaneous lichen planus: our experience with 50 patients. Photodermatol Photoimmunol Photomed. 2008 Apr;24(2):83-6. Abstract
49. Saricaoglu H, Karadogan SK, Baskan EB, et al. Narrowband UVB therapy in the treatment of lichen planus. Photodermatol Photoimmunol Photomed. 2003 Oct;19(5):265-7. Abstract
50. Taneja A, Taylor CR. Narrow-band UVB for lichen planus treatment. Int J Dermatol. 2002 May;41(5):282-3. Abstract
51. Gonzalez E, Momtaz-T K, Freedman S. Bilateral comparison of generalized lichen planus treated with psoralens and ultraviolet A. J Am Acad Dermatol. 1984 Jun;10(6):958-61. Abstract
52. Pigatto PD, Chiappino G, Bigardi A, et al. Cyclosporin A for treatment of severe lichen planus. Br J Dermatol. 1990 Jan;122(1):121-3. Abstract
53. Ho VC, Gupta AK, Ellis CN, et al. Treatment of severe lichen planus with cyclosporine. J Am Acad Dermatol. 1990 Jan;22(1):64-8. Abstract
54. Massa MC, Rogers RS 3rd. Griseofulvin therapy of lichen planus. Acta Derm Venereol. 1981;61(6):547-50. Abstract
55. Shelley WB, Shelley ED. Urinary tract infection as a cause of lichen planus: metronidazole therapy. J Am Acad Dermatol 1984 May;10(5 Pt 2):905-7. Abstract
56. Büyük AY, Kavala M. Oral metronidazole treatment of lichen planus. J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):260-2. Abstract
57. Wahba-Yahav AV. Idiopathic lichen planus: treatment with metronidazole. J Am Acad Dermatol. 1995 Aug;33(2 Pt 1):301-2. Abstract
58. Bauza A, Espana A, Gil P, et al. Successful treatment of lichen planus with sulfasalazine in 20 patients. Int J Dermatol. 2005 Feb;44(2):158-62. Abstract
59. Verma KK, Sirka CS, Khaitan BK. Generalized severe lichen planus treated with azathioprine. Acta Derm Venereol. 1999 Nov;79(6):493. Abstract
60. Verma KK, Mittal R, Manchanda Y. Azathioprine for the treatment of severe erosive oral and generalized lichen planus. Acta Derm Venereol. 2001 Oct-Nov;81(5):378-9. Abstract
61. Lear JT, English JSC. Erosive and generalized lichen planus responsive to azathioprine. Br J Dermatol. 1996 Jan;21(1):56-7. Abstract
62. Nousari HC, Goyal S, Anhalt GJ. Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil. Arch Dermatol. 1999 Nov;135(11):1420-1. Abstract
63. Turan H, Baskan EB, Tunali S, et al. Methotrexate for the treatment of generalized lichen planus. J Am Acad Dermatol. 2009 Jan;60(1):164-6. Abstract
64. Hazra SC, Choudhury AM, Khondker L, et al. Comparative efficacy of methotrexate and mini pulse betamethasone in the treatment of lichen planus. Mymensingh Med J. 2013 Oct;22(4):787-97. Abstract
65. Assouly P, Reygagne P. Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg. 2009 Mar;28(1):3-10. Abstract
66. Kang H, Alzolibani AA, Otberg N, et al. Lichen planopilaris. Dermatol Ther. 2008 Jul-Aug;21(4):249-56. Abstract
67. Chieregato C, Zini A, Barba A, et al. Lichen planopilaris: report of 30 cases and review of the literature. Int J Dermatol. 2003 May;42(5):342-5. Abstract
68. Mirmirani P, Willey A, Price VH. Short course of oral cyclosporine in lichen planopilaris. J Am Acad Dermatol. 2003 Oct;49(4):667-71. Abstract
69. Tursen U, Api H, Kaya T, et al. Treatment of lichen planopilaris with mycophenolate mofetil. Dermatol Online J. 2004 Jul 15;10(1):24. Abstract
70. Scully C, Carrozzo M. Oral mucosal disease: Lichen planus. Br J Oral Maxillofac Surg. 2008 Jan;46(1):15-21. Abstract
71. Reddy RL, Reddy RS, Ramesh T, et al. Randomized trial of aloe vera gel vs triamcinolone acetonide ointment in the treatment of oral lichen planus. Quintessence Int. 2012 Oct;43(9):793-800. Abstract
72. Davari P, Hsiao HH, Fazel N. Mucosal lichen planus: an evidence-based treatment update. Am J Clin Dermatol. 2014 Jul;15(3):181-95. Abstract
73. Ho J, Hantash BM. Systematic review of current systemic treatment options for erosive lichen planus. Expert Review of Dermatology. 2012;7:269-82.Full text
74. Carbone M, Conrotto D, Carrozzo M, et al. Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis. 1999 Jan;5(1):44-9. Abstract
75. Lozada-Nur F, Miranda C, Maliksi R. Double-blind clinical trial of 0.05% clobetasol propionate (corrected from proprionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol. 1994 Jun;77(6):598-604. Abstract
76. Thongprasom K, Luengvisut P, Wongwatanakij A, et al. Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: a 2-year follow-up. J Oral Pathol Med. 2003 Jul;32(6):315-22. Abstract
77. Tyldesley WR, Harding SM. Betamethasone valerate aerosol in the treatment of oral lichen planus. Br J Dermatol. 1977 Jun;96(6):659-62. Abstract
78. Voute AB, Schulten EA, Langendijk PN, et al. Fluocinonide in an adhesive base for treatment of oral lichen planus: a double-blind, placebo-controlled clinical study. Oral Surg Oral Med Oral Pathol. 1993 Feb;75(2):181-5. Abstract
79. Boisnic S, Licu D, Ben Slama L, et al. Topical retinaldehyde treatment in oral lichen planus and leukoplakia. Int J Tissue React. 2002;24(4):123-30. Abstract
80. Buajeeb W, Kraivaphan P, Pobrurksa C. Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Jan;83(1):21-5. Abstract
81. Giustina TA, Stewart JC, Ellis CN, et al. Topical application of isotretinoin gel improves oral lichen planus: a double-blind study. Arch Dermatol. 1986 May;122(5):534-6. Abstract
82. Hersle K, Mobacken H, Sloberg K, et al. Severe oral lichen planus: treatment with an aromatic retinoid (etretinate). Br J Dermatol. 1982 Jan;106(1):77-80. Abstract
83. Petruzzi M, De Benedittis M, Grassi R, et al. Oral lichen planus: a preliminary clinical study on treatment with tazarotene. Oral Dis. 2002 Nov;8(6):291-5. Abstract
84. Sloberg K, Hersle K, Mobacken H, et al. Severe oral lichen planus: remission and maintenance with vitamin A analogues. J Oral Pathol. 1983 Dec;12(6):473-7. Abstract
85. Zegarelli DJ. Treatment of oral lichen planus with topical vitamin A acid. J Oral Med. 1984 Jul-Sep;39(3):186-91. Abstract
86. Petruzzi M, Lucchese A, Lajolo C, et al. Topical retinoids in oral lichen planus treatment: an overview. Dermatology. 2013;226(1):61-7. Abstract
87. Samycia M, Lin AN. Efficacy of topical calcineurin inhibitors in lichen planus. J Cutan Med Surg. 2012 Jul-Aug;16(4):221-9. Abstract
88. Al Johani KA, Hegarty AM, Porter SR, et al. Calcineurin inhibitors in oral medicine. J Am Acad Dermatol. 2009 Nov;61(5):829-40. Abstract
89. Byrd JA, Davis MD, Bruce AJ, et al. Response of oral lichen planus to topical tacrolimus in 37 patients. Arch Dermatol. 2004 Dec;140(12):1508-12.Full text Abstract
90. Hodgson TA, Sahni N, Kaliakatsou F, et al. Long-term efficacy and safety of topical tacrolimus in the management of ulcerative/erosive oral lichen planus. Eur J Dermatol. 2003 Sep-Oct;13(5):466-70. Abstract
91. Kaliakatsou F, Hodgson TA, Lewsey JD, et al. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol. 2002 Jan;46(1):35-41. Abstract
92. Lozada-Nur FI, Sroussi HY. Tacrolimus powder in Orabase 0.1% for the treatment of oral lichen planus and oral lichenoid lesions: an open clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Dec;102(6):744-9. Abstract
93. Olivier V, Lacour JP, Mousnier A, et al. Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. Arch Dermatol. 2002 Oct;138(10):1335-8.Full text Abstract
94. Rozycki TW, Rogers RS 3rd, Pittelkow MR, et al. Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. J Am Acad Dermatol. 2002 Jan;46(1):27-34. Abstract
95. Volz T, Caroli U, Ludtke H, et al. Pimecrolimus cream 1% in erosive oral lichen planus – a prospective randomized double blind vehicle controlled study. Br J Dermatol. 2008 Sep;159(4):936-41. Abstract
96. Radfar L, Wild RC, Suresh L. A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Feb;105(2):187-93. Abstract
97. Dissemond J. Pimecrolimus in an adhesive ointment is safe and effective in long-term treatment for oral lichen planus. J Eur Acad Dermatol Venereol. 2008 Aug;22(8):1009-11. Abstract
98. Day I, Lin AN. Use of pimecrolimus cream in disorders other than atopic dermatitis. J Cutan Med Surg. 2008 Jan-Feb;12(1):17-26. Abstract
99. Cheng S, Kirtschig G, Cooper S, et al. Interventions for erosive lichen planus affecting mucosal sites. Cochrane Database Syst Rev. 2012;(2):CD008092.Full text Abstract
100. Lodi G, Carrozzo M, Furness S, et al. Interventions for treating oral lichen planus: a systematic review. Br J Dermatol. 2012 May;166(5):938-47. Abstract
101. Jin X, Lu S, Xing X, et al. Thalidomide: features and potential significance in oral precancerous conditions and oral cancer. J Oral Pathol Med. 2013 May;42(5):355-62. Abstract
102. Cooper SM, Wojnarowska F. Influence of treatment of erosive lichen planus of the vulva on its prognosis. Arch Dermatol. 2006 Mar;142(3):289-94.Full text Abstract
103. Edwards SK, Bates CM, Lewis F, et al. 2014 UK national guideline on the management of vulval conditions. Int J STD AIDS. 2015 Aug;26(9):611-24. Abstract
104. Byrd JA, Davis MD, Rogers RS 3rd. Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus. Arch Dermatol. 2004 Jun;140(6):715-20.Full text Abstract
105. Lonsdale-Eccles AA, Velangi S. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series. Br J Dermatol. 2005 Aug;153(2):390-4. Abstract
106. Goldstein AT, Thaci D, Luger T. Topical calcineurin inhibitors for the treatment of vulvar dermatoses. Eur J Obstet Gynecol Reprod Biol. 2009 Sep;146(1):22-9. Abstract
107. Abell E, Samman PD. Intradermal triamcinolone treatment of nail dystrophies. Br J Dermatol. 1973 Aug;89(2):191-7. Abstract
108. Tosti A, Peluso AM, Fanti PA, et al. Nail lichen planus: clinical and pathological study of twenty-four patients. J Am Acad Derm. 1993 May;28(5 Pt 1):724-30. Abstract
109. Ekelem C, Juhasz M, Khera P, et al. Utility of Naltrexone Treatment for Chronic Inflammatory Dermatologic Conditions: A Systematic Review. JAMA Dermatol. 2019 Feb 1;155(2):229-36.Full text Abstract
110. Sigurgeirsson B, Lindelof B. Lichen planus and malignancy: an epidemiologic study of 2071 patients and a review of the literature. Arch Dermatol. 1991 Nov;127(11):1684-8. Abstract
111. Gonzalez-Moles MA, Scully C, Gil-Montoya JA. Oral lichen planus: controversies surrounding malignant transformation. Oral Dis. 2008 Apr;14(3):229-43. Abstract
Use of this content is subject to our disclaimer